Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients.
Chanisa ThonusinNichanan OsataphanKrit LeemasawatWichwara NawaraSirawit SriwichaiinSiriporn SupakhamSiriluck GunaparnNattayaporn ApaijaiAreewan SomwangprasertArintaya PhrommintikulSiriporn C ChattipakornSiriporn C ChattipakornPublished in: Journal of translational medicine (2024)
The study was conducted under ethical approval from the Institutional Review Board of the Faculty of Medicine, Chiang Mai University (Registration number: MED-2563-07001; Date: April 28, 2020). The study also complied with the Declaration of Helsinki.